Prognostic Value of Molecular Markers for Guiding Post-Remission Therapy in Patients with De Novo Acute Myeloid Leukemia (AML) and Intermediate-Risk Cytogenetics.

被引：0

作者：

Pratcorona, Marta ^{[1
]}

Camos, Mireia ^{[2
]}

Torrebadell, Montserrat ^{[2
]}

Rozman, Maria ^{[2
]}

Carrio, Ana ^{[2
]}

Costa, Dolors ^{[2
]}

Valera, Alexandra ^{[2
]}

Campo, Elias ^{[2
]}

Montserrat, Emili ^{[1
]}

Esteve, Jordi ^{[1
]}

机构：

[1] Univ Barcelona, IDIBAPS, Hosp Clin, Inst Hematol & Oncol,Dept Hematol, Barcelona, Spain

[2] Univ Barcelona, IDIBAPS, Hosp Clin, Hematopathol Unit, Barcelona, Spain

来源：

BLOOD | 2008年 / 112卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：875 / 876

页数：2

共 50 条

[31] Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG AML97 study
Sakamaki, Hisashi
Miyawaki, Shuichi
Ohtake, Shigeki
Emi, Nobuhiko
Yagasaki, Fumiharu
Mitani, Kinuko
Matsuda, Shin
Kishimoto, Yuji
Miyazaki, Yasushi
Asou, Norio
Takahashi, Masatomo
Ogawa, Yoshiaki
Honda, Sumihisa
Ohno, Ryuzo
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (02) : 284 - 292
[32] Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG AML97 study
Hisashi Sakamaki
Shuichi Miyawaki
Shigeki Ohtake
Nobuhiko Emi
Fumiharu Yagasaki
Kinuko Mitani
Shin Matsuda
Yuji Kishimoto
Yasushi Miyazaki
Norio Asou
Masatomo Takahashi
Yoshiaki Ogawa
Sumihisa Honda
Ryuzo Ohno
International Journal of Hematology, 2010, 91 : 284 - 292
[33] Prognostic value of serum progranulin in de novo adult acute myeloid leukemia patients
Azazzi, Mohamed O.
El-Ghammaz, Amro M. S.
Mohamed, Haydi S.
HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2023, 45 (01) : 25 - 31
[34] Prognostic Value of Serum Progranulin in De Novo Adult Acute Myeloid Leukemia Patients
Azzazi, Mohamed
El Ghammaz, Amro
Mohamed, Haydi Sayed
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S225 - S225
[35] Fluoroquinolone Prophylaxis in Acute Myeloid Leukemia (AML) Patients Undergoing Post-Remission Chemotherapy Reduces Hospital Admission Rates
Kusick, Karissa
Earl, Marc
Gallagher, Erika M.
Yeh, Jun-Yen
Advani, Anjali S.
Kalaycio, Matt
Copelan, Edward A.
Sekeres, Mikkael A.
BLOOD, 2011, 118 (21) : 1103 - 1103
[36] Prognostic Significance of Histone (H4) Acetylation In Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with Intermediate Risk Cytogenetics
Shadman, Mazyar
Gibson, Sarah
Cotta, Claudiu
Saunthararajah, Yogen
Hsi, Eric
Copelan, Edward
Kalaycio, Matt
Sekeres, Mikkael A.
Sobecks, Ronald
Effinger, Meagan
Advani, Anjali S.
BLOOD, 2010, 116 (21) : 1128 - 1128
[37] Azacitidine in Patients with Acute Myeloid Leukemia: Impact of Intermediate-Risk Vs High-Risk Cytogenetics on Patient Outcomes
Pleyer, Lisa
Burgstaller, Sonja
Stauder, Reinhard
Girschikofsky, Michael
Linkesch, Werner
Pfeilstoecker, Michael
Autzinger, Eva Maria
Tinchon, Christoph
Sliwa, Thamer
Lang, Alois
Sperr, Wolfgang R.
Geissler, Dietmar
Krippl, Peter
Voskova, Daniela
Rossmann, Dieter H.
Schlick, Konstantin
Thaler, Josef
Halter, Britta
Machherndl-Spandl, Sigrid
Theiler, Georg
Valent, Peter
Eckmuellner, Otto
Greil, Richard
BLOOD, 2014, 124 (21)
[38] 5′-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics
Diaz-Santa, Johana
Rodriguez-Romanos, Rocio
Coll, Rosa
Osca, Gemma
Pratcorona, Marta
Gonzalez-Bartulos, Marta
Garrido, Ana
Angona, Anna
Talarn, Carme
Tormo, Mar
Arnan, Montserrat
Vives, Susanna
Salamero, Olga
Tuset, Esperanza
Lloveras, Natalia
Diez, Isabel
Zamora, Lurdes
Bargay, Joan
Sampol, Antonia
Cruz, David
Vila, Jordi
Sitges, Marta
Garcia, Antoni
Vall-Llovera, Ferran
Esteve, Jordi
Sierra, Jorge
Gallardo, David
EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (06) : 755 - 764
[39] Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years
J J Cornelissen
J Versluis
J R Passweg
W L J van Putten
M G Manz
J Maertens
H B Beverloo
P J M Valk
M van Marwijk Kooy
P W Wijermans
M R Schaafsma
B J Biemond
M-C Vekemans
D A Breems
L F Verdonck
M F Fey
M Jongen-Lavrencic
J J W M Janssen
G Huls
J Kuball
T Pabst
C Graux
H C Schouten
A Gratwohl
E Vellenga
G Ossenkoppele
B Löwenberg
Leukemia, 2015, 29 : 1041 - 1050
[40] A Novel Prognostic Model for Risk Stratification in Younger Patients with Intermediate Risk Acute Myeloid Leukemia (AML)
Nazha, Aziz
Seastone, David
Radivoyevitch, Tom
Dienes, Brittney
Przychodzen, Bartlomiej
Carew, Jennifer
Mukherjee, Sudipto
Carraway, Hetty E.
Advani, Anjali
Kalaycio, Matt
Gerds, Aaron T.
Maciejewski, Jaroslaw P.
Sekeres, Mikkael A.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S195 - S196

← 1 2 3 4 5 →